基于结构的设计的泛选择性环基对于三个人体免疫蛋白酶组活性位点
Patrick M Dekker1, Eva M Huber2, Elmer Maurits1
1Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Journal of medicinal chemistry
|January 8, 2026
概括
研究人员发现了一种针对免疫蛋白质酶的新药类,有可能减少当前蛋白质酶抑制剂的副作用. 这为治疗癌症和自身免疫性疾病提供了更有选择性的方法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白质酶体抑制剂,如博特佐米布,是有效的癌症治疗方法,但由于抑制构成蛋白质酶体,导致副作用.
- 当前蛋白质酶体抑制剂的毒性与它们抑制构成性蛋白质酶体活性有关.
研究的目的:
- 发现一种新的抑制剂类别,对免疫蛋白质酶具有选择性,而不是构成性蛋白质酶.
- 确定一种主要化合物,用于开发针对免疫蛋白酶驱动疾病的改进疗法.
主要方法:
- 结构导向的药物发现方法.
- 酸环氧抑制剂的鉴定和表征.
- 测试以确定免疫蛋白质酶和构成性蛋白质酶子单元的抑制功效 (IC50) 和选择性比.
主要成果:
- 鉴定了BocPip-Ser (化合物 8),一种全免疫蛋白酶体抑制剂.
- 化合物8表现出对所有三个人类免疫蛋白酶组活性位点 (IC50 ≤ 0.92 μM) 的强烈抑制.
- 在构成性蛋白酶活性位点上获得了优异的选择性 (选择性比> 13).
结论:
- 博克皮普-塞尔是开发选择性免疫蛋白酶体抑制剂的有希望的化合物.
- 这种新型的抑制剂可以改善血液癌症和自身免疫性疾病的治疗方法.
- 选择性向免疫蛋白质酶体可能会减轻与当前蛋白质酶体抑制剂相关的副作用.
更多相关视频
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
2.5K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.8K
相关概念视频
01:17The Proteasome Structure
1.6K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.6K
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K